Virtu Financial LLC Protara Therapeutics, Inc. Transaction History

Virtu Financial LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 07, 2022	BUY	$2.96 - $4.27 $6,991 - $10,085	2,362 Added 23.38%	12,465 $37,000
Q2 2022 Aug 09, 2022	BUY	$2.8 - $5.33 $28,288 - $53,848	10,103 New	10,103 $30,000
Q4 2021 Feb 17, 2022	SELL	$6.15 - $7.76 $105,349 - $132,928	-17,130 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$6.38 - $9.3 $109,289 - $159,309	17,130 New	17,130 $119,000

10.7M

1.8K

Ticker TARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 11,267,400
Market Cap $25.8M
Description
Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the identifying and advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy for the treatment of lymphatic malformations. It also develops intravenous choline chlorid...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.